Journal Club Article Archive

Title Author Journal Issue
JPEN Journal Club 82. Stepped-wedge cluster randomized trials
Ronald L. Koretz, MD
First Published January 31, 2024
JPEN Journal Club 81. Not all systematic reviews are created equal
Ronald L. Koretz, MD
First Published November 28, 2023
JPEN Journal Club 80. Prespecified outcomes
Ronald L. Koretz, MD
First Published October 18, 2023
JPEN Journal Club 79. If it may, it also may not
Ronald L. Koretz, MD
First Published July 27, 2023
JPEN Journal Club 78. Response-adaptive randomization
Ronald L. Koretz, MD
First Published June 28, 2023
JPEN Journal Club 77. Adjusting for confounders
Ronald L. Koretz, MD
First Published April 8, 2023
JPEN Journal Club 76. Randomized crossover trials
Ronald L. Koretz, MD  First Published March 4, 2023
JPEN Journal Club 75. When the headline does not match the study
Ronald L. Koretz, MD  First Published January 16, 2023
JPEN Journal Club 74. Regression to the mean
Ronald L. Koretz, MD First Published November 29, 2022
JPEN Journal Club 73. When it is Too Good to be True
Ronald L. Koretz, MD
First Published October 1, 2022
JPEN Journal Club 72. The Devil in the Details Ronald L. Koretz, MD
First Published August 16, 2022
JPEN Journal Club 71. Statistical Significance vs Truth Ronald L. Koretz, MD
First Published June 21, 2022
JPEN Journal Club 70. Proof of Concept
Ronald L. Koretz, MD
First Published May 8, 2022
JPEN Journal Club 69. Umbrella Reviews Ronald L. Koretz, MD First Published February 28, 2022
JPEN Journal Club 68. Type I Errors Ronald L. Koretz, MD First Published January 24, 2022
JPEN Journal Club 67. Fixed-effect and Random-effects Models Ronald L. Koretz, MD First Published December 3, 2021
JPEN Journal Club 66. Mendelian Randomization Ronald L. Koretz, MD First Published November 16, 2021
JPEN Journal Club 65. Selective Citation Ronald L. Koretz, MD First Published September 5, 2021
JPEN Journal Club 64. Incorrect Statistics Ronald L. Koretz, MD First Published August 1, 2021
JPEN Journal Club 63. Retrospective Analyses of Prospective Studies Ronald L. Koretz, MD First Published May 12, 2021
JPEN Journal Club 62. Reporting of Randomized Trials Ronald L. Koretz, MD  First Published April 7, 2021
JPEN Journal Club 61. Testing Hypotheses Ronald L. Koretz, MD  First Published March 11, 2021
JPEN Journal Club 60. AGREE II
Ronald L. Koretz, MD  First Published January 19, 2021 
JPEN Journal Club 59. Standards for Review Articles Ronald L. Koretz, MD  First Published December 3, 2020
JPEN Journal Club 58. Case Report Ronald L. Koretz, MD  First Published September 11, 2020 
JPEN Journal Club 57. The Hawthorne Effect  Ronald L. Koretz, MD  First Published July 22, 2020 
JPEN Journal Club 56. Primary Outcomes Ronald L. Koretz, MD  First Published June 29, 2020 
JPEN Journal Club 55. Best‐ and Worst‐Case Scenarios Ronald L. Koretz, MD  First Published May 22, 2020 
JPEN Journal Club 54. Correlation Coefficients  Ronald L. Koretz, MD  First Published May 15, 2020 
JPEN Journal Club 53. The Narrative Review  Ronald L. Koretz, MD  First Published March 30, 2020 
JPEN Journal Club 52. What Evidence Will Change Minds?  Ronald L. Koretz, MD  First Published March 6, 2020 
JPEN Journal Club 51. Confidence Intervals  Ronald L. Koretz, MD  First Published February 3, 2020 
JPEN Journal Club 50. Trial Sequential Analysis Ronald L. Koretz, MD  First Published February 4, 2020 
JPEN Journal Club 49. Pilot Trials Ronald L. Koretz, MD October 2019
JPEN Journal Club 48. When Systematic Reviews Differ Ronald L. Koretz, MD September 2019
JPEN Journal Club 47. How Good Should Evidence Be? Ronald L. Koretz, MD August 2019
JPEN Journal Club 46. Data Dredging Ronald L. Koretz, MD May 2019
JPEN Journal Club 45. Cluster Randomization Ronald L. Koretz, MD April 2019
JPEN Journal Club 44. When Not to Combine Data Ronald L. Koretz, MD March 2019
JPEN Journal Club 43. Stratification Ronald L. Koretz, MD February 2019
JPEN Journal Club 42. Factorial Design Ronald L. Koretz, MD February 2019
JPEN Journal Club 41. Propensity Scoring Ronald L. Koretz, MD January 2019
JPEN Journal Club 40. Differences in Nominal Significance Ronald L. Koretz, MD November 2018; 43 (2)
JPEN Journal Club 39. Validating a Surrogate Ronald L. Koretz, MD October 2018; 43 (1)
JPEN Journal Club 38. One‐Tailed Testing Ronald L. Koretz, MD September 2018; 42 (8)
JPEN Journal Club 37. Placebos and Nocebos Ronald L. Koretz, MD August 2018; 42 (7)
JPEN Journal Club 36. Quasirandomization Ronald L. Koretz, MD June 2018; 42 (6)
JPEN Journal Club 35. Selective Data Presentation Ronald L. Koretz, MD May 2018; 42 (5)
JPEN Journal Club 34. Suspecting Causation in an Association Ronald L. Koretz, MD March 2018; 42 (4)
JPEN Journal Club 33. The Type II Error Ronald L. Koretz, MD January 2018; 42 (3)
JPEN Journal Club 32. Adjusting for Confounding Ronald L. Koretz, MD January 2018; 42 (2)
JPEN Journal Club 31. Heterogeneity Ronald L. Koretz, MD November 2017; 41 (8)
JPEN Journal Club 30. The Cochrane Systematic Review—Data Collection and Assessment Ronald L. Koretz, MD October 2017; 41 (7)
JPEN Journal Club 29. The Cochrane Systematic Review—Methodology Ronald L. Koretz, MD October 2017; 41 (6)
JPEN Journal Club 28. Dealing With Dropouts Ronald L. Koretz, MD July 2017; 41 (5)
JPEN Journal Club 27. Vested Interests Ronald L. Koretz, MD May 2017; 41 (4)
JPEN Journal Club 26. Small Trials With Dramatic Findings Ronald L. Koretz, MD March 2017; 41 (3)
JPEN Journal Club 25. Study Design Ronald L. Koretz, MD January 2017; 41 (2)
JPEN Journal Club 24. Study Premise Ronald L. Koretz, MD December 2016; 41 (1)
JPEN Journal Club 23. GRADEing Guidelines Ronald L. Koretz, MD November 2016; 40 (8)
JPEN Journal Club 22. Superiority, Noninferiority, and Equivalence Ronald L. Koretz, MD September 2016; 40 (7)
JPEN Journal Club 21. Systematic Reviews and Strength of Evidence Ronald L. Koretz, MD August 2016; 40 (6)
JPEN Journal Club 20. Is the Guideline Already Out of Date? Ronald L. Koretz, MD July 2016; 40 (5)
JPEN Journal Club 19. The Data vs the Message Ronald L. Koretz, MD May 2016; 40 (4)